Gracell Biotechnologies Inc. (GRCL) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts GRCL Hot Sheet
Join SI Premium – FREE
Gracell Biotechnologies Inc. (NASDAQ: GRCL) reported Q1 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Gracell Biotechnologies Inc. (GRCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
- Cummins wins battery storage contract for U.S. data center project
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
